Status: Not yet recruiting
A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients
The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: SciNeuroUpdated: Sep 30, 2025
Eligibility criteria
Confirmed diabetes mellitus Type 1 or Type 2, with stable glycemic control [+3]